|
1
|
NCD Risk Factor Collaboration (NCD-RisC),
. Worldwide trends in diabetes since 1980: A pooled analysis of 751
population-based studies with 4.4 million participants. Lancet.
387:1513–1530. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
He G, Liang Y, Chen Y, Yang W, Liu JS,
Yang MQ and Guan R: A hotspots analysis-relation discovery
representation model for revealing diabetes mellitus and obesity.
BMC Syst Biol 12(Suppl 7). 1162018. View Article : Google Scholar
|
|
3
|
Scheen AJ and Paquot N: Obesity. A new
paradigm for treating obesity and diabetes mellitus. Nat Rev
Endocrinol. 11:196–198. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Guilherme A, Virbasius JV, Puri V and
Czech MP: Adipocyte dysfunctions linking obesity to insulin
resistance and type 2 diabetes. Nat Rev Mol Cell Biol. 9:367–377.
2008. View
Article : Google Scholar : PubMed/NCBI
|
|
5
|
Hasegawa Y, Ikeda K, Chen Y, Alba DL,
Stifler D, Shinoda K, Hosono T, Maretich P, Yang Y, Ishigaki Y, et
al: Repression of adipose tissue fibrosis through a PRDM16-GTF2IRD1
complex improves systemic glucose homeostasis. Cell Metab.
27:180–194.e6. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Chen L, Lu W and Li Y: Berberine
ameliorates type 2 diabetes via modulation of
Bifidobacterium species, tumor necrosis factor-α, and
lipopolysaccharide. Int J Clin Exp Med. 9:9365–9372. 2016.
|
|
7
|
Chen X, Yu J and Shi J: Management of
diabetes mellitus with puerarin, a natural isoflavone from pueraria
lobata. Am J Chin Med. 46:1771–1789. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Chen M, Liao Z, Lu B, Wang M, Lin L, Zhang
S, Li Y, Liu D, Liao Q and Xie Z: Huang-Lian-Jie-Du-Decoction
ameliorates hyperglycemia and insulin resistant in association with
gut microbiota modulation. Front Microbiol. 9:23802018. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhao P, Zhao C, Li X, Gao Q, Huang L, Xiao
P and Gao W: The genus Polygonatum: A review of ethnopharmacology,
phytochemistry and pharmacology. J Ethnopharmacol. 214:274–291.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Cui X, Wang S, Cao H, Guo H, Li Y, Xu F,
Zheng M, Xi X and Han C: A review: The bioactivities and
pharmacological applications of Polygonatum sibiricum
polysaccharides. Molecules. 23:E11702018. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Liu N, Dong Z, Zhu X, Xu H and Zhao Z:
Characterization and protective effect of Polygonatum
sibiricum polysaccharide against cyclophosphamide-induced
immunosuppression in Balb/c mice. Int J Biol Macromol. 107:796–802.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yelithao K, Surayot U, Lee JH and You S:
RAW264.7 cell activating glucomannans extracted from rhizome of
Polygonatum sibiricum. Prev Nutr Food Sci. 21:245–254. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zeng GF, Zhang ZY, Lu L, Xiao DQ, Xiong
CX, Zhao YX and Zong SH: Protective effects of Polygonatum
sibiricum polysaccharide on ovariectomy-induced bone loss in
rats. J Ethnopharmacol. 136:224–229. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhu X, Wu W, Chen X, Yang F, Zhang J and
Hou J: Protective effects of Polygonatum sibiricum
polysaccharide on acute heart failure in rats 1. Acta Cir Bras.
33:868–878. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wang Y, Qin S, Pen G, Chen D, Han C, Miao
C, Lu B, Su C, Feng S, Li W, et al: Original research: Potential
ocular protection and dynamic observation of Polygonatum
sibiricum polysaccharide against streptozocin-induced diabetic
rats' model. Exp Biol Med (Maywood). 242:92–101. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wang Y, Lan C, Liao X, Chen D, Song W and
Zhang Q: Polygonatum sibiricum polysaccharide potentially
attenuates diabetic retinal injury in a diabetic rat model. J
Diabetes Investig. 10:915–924. 2019.PubMed/NCBI
|
|
17
|
Ahmed SM, Luo L, Namani A, Wang XJ and
Tang X: Nrf2 signaling pathway: Pivotal roles in inflammation.
Biochim Biophys Acta Mol Basis Dis. 1863:585–597. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Lu MC, Ji JA, Jiang ZY and You QD: The
Keap1-Nrf2-ARE pathway as a potential preventive and therapeutic
target: An Update. Med Res Rev. 36:924–963. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Yoo EJ, Lee HH, Ye BJ, Lee JH, Lee CY,
Kang HJ, Jeong GW, Park H, Lim SW, Lee-Kwon W, et al: TonEBP
suppresses the HO-1 gene by blocking recruitment of Nrf2 to its
promoter. Front Immunol. 10:8502019. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Cheng Y, Yang C, Luo D, Li X, Le XC and
Rong J: N-Propargyl caffeamide skews macrophages towards a
resolving M2-like phenotype against myocardial ischemic injury via
activating Nrf2/HO-1 pathway and inhibiting NF-kB pathway. Cell
Physiol Biochem. 47:2544–2557. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yu ZW, Li D, Ling WH and Jin TR: Role of
nuclear factor (erythroid-derived 2)-like 2 in metabolic
homeostasis and insulin action: A novel opportunity for diabetes
treatment? World J Diabetes. 3:19–28. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Liao SP, Wu WQ, Zeng J and Wu Y: miR-146a
regulates inflammatory cytokines and reverses high-glucose- and
high-insulin-induced insulin resistance in 3T3-L1 adipocytes by
targeting Traf6 through the NF-κB signaling pathway. Int J Clin Exp
Med. 11:1708–1716. 2018.
|
|
23
|
Liu C, Feng X, Li Q, Wang Y, Li Q and Hua
M: Adiponectin, TNF-α and inflammatory cytokines and risk of type 2
diabetes: A systematic review and meta-analysis. Cytokine.
86:100–109. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Bastard JP, Maachi M, Lagathu C, Kim MJ,
Caron M, Vidal H, Capeau J and Feve B: Recent advances in the
relationship between obesity, inflammation, and insulin resistance.
Eur Cytokine Netw. 17:4–12. 2006.PubMed/NCBI
|
|
25
|
Su YC, Ou HY, Wu HT, Wu P, Chen YC, Su BH,
Shiau AL, Chang CJ and Wu CL: Prothymosin-α overexpression
contributes to the development of insulin resistance. J Clin
Endocrinol Metab. 100:4114–4123. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Nie Y, Ma RC, Chan JC, Xu H and Xu G:
Glucose-dependent insulinotropic peptide impairs insulin signaling
via inducing adipocyte inflammation in glucose-dependent
insulinotropic peptide receptor-overexpressing adipocytes. FASEB J.
26:2383–2393. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Sun L, Li X, Li G, Dai B and Tan W:
Actinidia chinensis planch. improves the indices of antioxidant and
anti-inflammation status of type 2 diabetes mellitus by activating
Keap1 and Nrf2 via the upregulation of microRNA-424. Oxid Med Cell
Longev. 2017:70387892017. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Uruno A, Yagishita Y and Yamamoto M: The
Keap1-Nrf2 system and diabetes mellitus. Arch Biochem Biophys.
566:76–84. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Song Y, Huang L and Yu J: Effects of
blueberry anthocyanins on retinal oxidative stress and inflammation
in diabetes through Nrf2/HO-1 signaling. J Neuroimmunol. 301:1–6.
2016. View Article : Google Scholar : PubMed/NCBI
|
